Kewaunee Scientific Reports Results for First Quarter

Dienstag, 30.08.2016 17:56 von

PR Newswire

STATESVILLE, N.C., Aug. 30, 2016 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended July 31, 2016.

Sales for the quarter were $37,279,000, a 20% increase from sales of $31,089,000 in the prior year first quarter. Domestic sales for the quarter were $29,637,000, up 22% from sales of $24,315,000 in the first quarter of last year. International sales for the quarter were $7,642,000, up 13% from sales of $6,774,000 in the first quarter last year.

Net earnings for the quarter were up 38% at $1,300,000, or $0.48 per diluted share, as compared to net earnings of $940,000, or $0.35 per diluted share, in the first quarter last year.  

Both Domestic and International sales were strong during the quarter, as the Company successfully met the demands of the marketplace for laboratory furniture and scientific equipment. Domestically, both dealer sales and direct sales were strong across all markets served by the Company.  Internationally, the Company benefited from a large order in the Middle East that was partially delivered in the first quarter.

The order backlog was $86.2 million at July 31, 2016, as compared to $86.7 million at July 31, 2015, and $100.5 million at April 30, 2016.  The Company is currently competing for a number of large projects that, if won, would significantly strengthen the current order backlog.

The Company's balance sheet and financial condition remain strong. Unrestricted cash on hand was $6,711,000 at the end of the quarter, as compared to $2,899,000 at the end of the first quarter last year. Working capital was $30,815,000 as compared to $28,523,000 at the end of the first quarter last year. Short-term debt and interest rate swaps were $6,958,000 at the end of the quarter, as compared to $4,901,000 at the end of the first quarter last year, and long-term debt was $3,665,000 as compared to $4,086,000 at the end of the first quarter last year. The debt-to-equity ratio at July 31, 2016 was .27-to-1, as compared to .25-to-1 at July 31, 2015.

"We had a very strong first quarter with our Domestic and International businesses posting strong year-over-year sales growth," said David M. Rausch, Kewaunee's President and Chief Executive Officer. "We have grown our sales and net earnings, continuing to operate at high levels and benefiting from ongoing productivity improvements and cost reduction programs.

"Looking forward, I remain optimistic that sales will continue to increase in fiscal year 2017. I expect our earnings improvement to be sustainable as our order backlog and opportunities in the market remain strong."

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Products include steel, wood, and laminate casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin worksurfaces and sinks.

The Company's corporate headquarters is located in Statesville, North Carolina. Direct sales offices are located in the United States, India, Singapore, and China. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company's China headquarters, sales office, and assembly operation are located in Suzhou Industrial Park, China. Kewaunee Scientific's website is located at http://www.kewaunee.com.

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties and assumptions, including industry and economic conditions that could cause actual results to differ materially from those described in the forward-looking statements. Additional information concerning these factors is contained in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:  Thomas D. Hull III 

               704/871-3290

 

Kewaunee Scientific Corporation

Consolidated Statements of Operations (Unaudited)

(in thousands, except per share data)















Three months ended





July 31,





2016



2015

Net sales



$    37,279



$    31,089

Cost of products sold



30,140



25,246

Gross profit



7,139



5,843

Operating expenses



5,078



4,319

Operating earnings



2,061



1,524

Other income



119



102

Interest expense



(80)



(92)

Earnings before income taxes



2,100



1,534

Income tax expense



770



571

Net earnings



1,330



963

Less: net earnings attributable to the noncontrolling interest



30



23

Net earnings attributable to Kewaunee Scientific Corporation



$      1,300



$         940











Net earnings per share attributable to









    Kewaunee Scientific Corporation stockholders









       Basic



$0.48



$0.36

       Diluted



$0.48



$0.35











Weighted average number of common shares outstanding









       Basic



2,693



2,630

       Diluted



2,707



2,659





















Kewaunee Scientific Corporation

Condensed Consolidated Balance Sheets

(in thousands)















July 31,



April 30,





2016



2016

Assets



(Unaudited)





Cash and cash equivalents



$      6,711



$      5,222

Restricted Cash



1,626



1,567

Receivables, less allowances



30,517



27,835

Inventories



16,785



15,626

Prepaid expenses and other current assets



1,287



707

    Total Current Assets



56,926



50,957

Net property, plant and equipment



14,527



14,118

Other assets



6,955



7,330

Total Assets



$    78,408



$    72,405











Liabilities and Equity









Short-term borrowings and interest rate swaps



$      6,958



$      3,818

Current portion of long-term debt



421



421

Accounts payable



13,821



11,722

Other current liabilities



4,911



4,989

    Total Current Liabilities



26,111



20,950

Other non-current liabilities



12,638



12,903

    Total Liabilities



38,749



33,853

Noncontrolling interest



339



310

Kewaunee Scientific Corporation stockholders' equity



39,320



38,242

    Total Equity



39,659



38,552

Total Liabilities and Stockholders' Equity



$    78,408



$    72,405

Logo - http://photos.prnewswire.com/prnh/20160229/338700LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kewaunee-scientific-reports-results-for-first-quarter-300320422.html

SOURCE Kewaunee Scientific Corporation

Weitere Themen